Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity

Rasha T Hamza, Khaled S Awwad, Mohamed K Ali, Amira I Hamed, Rasha T Hamza, Khaled S Awwad, Mohamed K Ali, Amira I Hamed

Abstract

Background: Recently, vitamin D deficiency has been implicated as a potential environmental factor triggering some autoimmune disorders, including systemic lupus erythematosus (SLE)). In addition, patients with SLE, especially those with increased disease activity, were suggested to have decreased vitamin D level, suggesting that vitamin D might play a role in regulating autoantibody production.

Material/methods: To assess 25 hydroxy vitamin D [25(OH)D] status in Egyptian patients with SLE and its relation to disease activity. Clinical evaluation and assay of serum 25(OH)D, total calcium, phosphorous, alkaline phosphatase (ALP) and parathyroid hormone (PTH) were done on 60 SLE patients in comparison to 60 matched-healthy subjects. Serum 25(OH)D levels <30 and 10 ng/ml were defined as vitamin D insufficiency and deficiency, respectively.

Results: Serum 25(OH)D was significantly lower in patients than in controls (26.33 ± 12.05 vs. 42.66 ± 9.20 respectively, p < 0.0001), with 13.30% and 60% being deficient and insufficient, respectively. Serum 25(OH)D levels were lower with increased disease activity (p = 0.03) and frequency of photosensitivity(p = 0.02) and photoprotection (p = 0.002). Systemic lupus erythematosus disease activity index (SLEDAI) score (OR: 2.72, 95% CI: 1.42-5.18, P = 0.002), photosensitivity (OR: 3.6, 95% CI: 1.9-6.8, P < 0.01) and photoprotection (OR: 6.7, 95% CI: 2.9-8.8, P < 0.001) were significant predictors of 25(OH)D level among SLE cases.

Conclusions: Low vitamin D status is prevalent in Egyptian SLE patients despite plentiful exposure to sunlight throughout the year, and its level is negatively correlated to disease activity. Future studies looking at a potential role of vitamin D in the pathophysiology and treatment of SLE are warranted.

References

    1. Sypniewska G, Sobanska I, Pater A, et al. Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status? Med Sci Monit. 2010;16(2):CR96–101.
    1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81.
    1. AlSaleh J, Jassim V, ElSayed M. Clinical and immunological manifestations in 151 SLE patients living in Dubai. Lupus. 2008;17:62–66.
    1. Castro J, Balada E, Ordi-Ros J, Villardell-Tarres M. The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev. 2008;7:345–51.
    1. Cutolo M, Osta K. Review: vitamin D, immunity and lupus. Lupus. 2008;17:6–10.
    1. Chen S, Sims GP, Chen XX. Modulatory effects of 1,25-Dihydroxy vitamin D3 on human B ell differentiation. J Immunol. 2005;179:1634–47.
    1. Maalouf F, Gannage-Yared MH, Ezzedine J, et al. Middle East and North Africa consensus on osteoporosis. J Musculoskelet Neuronal Interact. 2007;7:131–43.
    1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–77.
    1. Liong MH, Socher SA, Lorson MG. Reliability and validity of the clinical assessment of disease activity in SLE. Arthritis Rheum. 1989;32:1107.
    1. Scharla S, Chapuy M, Schattauer V. Determination of 25-vitamin D in human serum and plasma. Exp Clin Endocrinol Diabetes. 1996;104:289–92.
    1. David HV, Zafer I. Alkaline phosphatase. In: Keneth H, Dallas W, Willis J, editors. Clinical methods. 3rd ed. Boston: Academic press; 1990. pp. 494–97.
    1. Michaylova V, Ilkova P. Photometric determination of micro amounts of calcium with arsenazo III. Anal Chim Acta. 1971;53:194–98.
    1. Babson AL. The Immulite 2000. Automated immunoassay system. J Clin Immunoassy. 1991;14:83–88.
    1. Chatfield S, Brand C, Ebeling P. Vitamin D deficiency in general medical in patients in summer and winter. Intern Med J. 2007;37:377–82.
    1. Ruiz-Irastorza G, Egurbide M, Olivares N. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology. 2008;47:920–23.
    1. Kamen D, Cooper G, Bouali H. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev. 2006;5:114–17.
    1. Damanhouri L. Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. Saudi Med J. 2009;30(10):1291–95.
    1. Thudi A, Yin S, Wandstrat AE, et al. Vitamin D levels and disease status in Texas patients with systemic lupus erythematosus. Am J Med Sci. 2008;335:99–104.
    1. Huisman AM, White KP, Algra A, et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol. 2001;28:2535–39.
    1. Sheng C, Sims G, Chen X. Modulatory effects of 1,25-dihydroxy vitamin D3 on human B cell differentiation. J Immunol. 2007;179:1634–47.
    1. Muller K, Kriegbaum N, Baslund B. Vitamin D metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D in patients with systemic lupus erythematosus. Clin Rheumatol. 1995;14:397–400.
    1. Redlich K, Ziegler S, Kiener H. Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus. Ann Rheum Dis. 2000;59:308–10.
    1. Carvalho J, Blank M, Kiss E. Antivitamin D, vitamin D in SLE: preliminary results. Ann NY Acad Sci. 2007;1109:550–57.
    1. Van Etten E, Branisteanu D, Overbergh L. Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone. Bone. 2003;32:397–404.
    1. Chen T, Chimeh F, Lu Z. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys. 2007;460:213–17.
    1. Ozakia Y, Nomura S, Nagahama M. Vitamin-D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus. Nephron. 2000;85:86–91.
    1. Huang C, Wu M, Wu J. No association of vitamin D receptor gene start codon fok 1 polymorphisms in Chinese patients with systemic lupus erythematosus. J Rheumatol. 2002;29:1211–13.
    1. Lee C, Almagor O, Dunlop D. Self-reported fractures and associated factors in women with systemic lupus erythematosus. J Rheumatol. 2007;34:2018.
    1. Broe K, Chen T, Weinberg J. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc. 2007;55:234–39.
    1. Wang TJ, Pencina MJ, Booth SL. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–11.
    1. Hypponen E, Boucher BJ, Berry DJ. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes. 2008;57:298–305.
    1. Vacca A, Cormier C, Piras M. Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis and SLE. J Rheumatol. 2009;36:1924–29.
    1. Borba V, Vieira J, Kasamatsu T. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int. 2008;20:427–33.
    1. Toloza S, Cole D, Gladman D. Vitamin D insufficiency in a large female SLE cohort. Lupus. 2010;19(1):13–19.
    1. David M, Rodney A, Roland F. Efficacy and safety of daily Risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: A randomized trial. J Bone Mineral Res. 2000;15:1006–13.
    1. Sen D, Keen R. Osteoporosis in systemic lupus erythematosus: prevention and treatment. Lupus. 2001;10:227–32.
    1. Barnes TC, Bucknall RC. Vitamin D deficiency in a patient with systemic lupus erythematosus. Rheumatology. 2004;43:393–94.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel